Alzheimer's drug hailed as a 'major' development
The first of a new class of treatments for Alzheimer's disease has been shown to be more than twice as effective as existing drugs in slowing progression of the condition, scientists said yesterday.
The drug, Rember, is the latest of a group of new treatments for the degenerative disease announced in the past two weeks but one with the greatest potential, experts said.
Rember is the first drug to act on the nerve tangles discovered by Alois Alzheimer a century ago which are thought to be the cause of the disease. The early (Phase 2) trial of 321 patients showed it slowed progression by 81 per cent compared with placebos.
The Alzheimer's Society described Rember as "a major new development" and said the results were "potentially exciting" but warned larger trials were needed. The drug was developed by scientists at the University of Aberdeen working with the Singapore-based company TauRx Therapeutics – a spin off from the university.
Professor Claude Wishcik, chairman of TauRx, who presented the findings at the International Conference on Alzheimer's Disease in Chicago yesterday, said: "This is an unprecedented result in the treatment of Alzheimer's Disease. We have demonstrated for the first time that it may be possible to arrest progression by targeting the tangles."
In a separate development, scientists from Imperial College London and the University of Uppsala, Sweden, reported that a new drug, PBT2, slows the build-up of protein leading to plaques. Results of the early trial, published in The Lancet Neurology and presented to the conference, show patients who took the drug over 12 weeks had significantly improved cognitive performance.
Life & Style blogs
Dozens of empty homes in two of Liverpool’s most deprived areas will be brought back into use thanks...
A roundup of the latest property news
Plus, do energy saving measures boost house prices?
The 10 Best Scotch Whiskies
The 10 Best new smartphones
Bollywood star, Shahrukh Khan, accused of choosing sex of baby
Uncooked curry leaves caused mass outbreak of salmonella in Newcastle, say health officials
Stripes set to be big for Dolce and Gabbana as fashion designers get 20 months in prison for tax evasion
- 1 Bankers could face jail after report urges the Government to introduce new criminal offence for reckless management
- 2 Breaking the Silence: In the reality of occupation, there are no Palestinian civilians – only potential terrorists
- 3 Richard Nieuwenhuizen death: Six teenagers and 50-year-old father convicted of manslaughter in shocking case of referee killed over a game of football
- 4 Exclusive: Newcastle's star talent-spotter on brink as Joe Kinnear sparks walkout
- 5 Vast methane 'plumes' seen in Arctic ocean as sea ice retreats
£500 - £600 per day: Orgtel: FX Options Front Office Java / C# Developer - Ba...
£600 - £700 per day: Orgtel: Project Manager - Front Office - Regulatory IT C...
£33000 - £35000 Per Annum: The Green Recruitment Company: The Green Recruitmen...
£21000 - £22000 per annum: Randstad Education Chelmsford: NQTs required now fo...